RSS

CYDY CytoDyn Inc

Last Post: 9:53 PM
Followers: 439
Posts Today: 1
Views Today: 53931

CYDY Stock Quote & Tools

$0.2283 ▲ +0.0229 (+11.14%) As of Oct 16, 3:59 PM EDT
Last0.2283
$ Chg0.0229
Open0.2050
High0.2300
Beta1.4964
Year High0.397
Market Cap335.42M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.68M
Volume3.96M
% Chg+11.14%
Prev Close0.2054
Low0.2050
VWAP0.21542
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences

CYDY Stock Message Board Discussion

  1. ohm20
  2. MD VIROLOGIST

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 20

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 20

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 18

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Claim Losses As Telix Pharmaceuticals Faces Lawsuit

Updated Category News Views 177

Understanding the Class Action Against Telix Pharmaceuticals In recent developments, investors in Telix Pharmaceuticals Limited are facing significant challenges. The recognized law firm Bronstein, Gewirtz & Grossman, LLC has announced the filing of a class action lawsuit against the company (NASDAQ: TLX) due to substantial investor losses. This lawsuit directly affects...

Continue Reading
Brookfield Business Partners Achieves Record Stock Performance

Updated Category News Views 181

Brookfield Business Partners LP (NYSE: BBU) marked a significant milestone back in 2024 when its stock climbed to an impressive 52-week high of $23.78. This surge wasn't just random luck; it was a testament to the company's robust growth trajectory over the past year, showcasing an eye-popping increase of 52.8% in stock value. Investor Confidence: The Pulse Behind Stock...

Continue Reading
Financial Institutions, Inc. Boosts Dividend to Support Growth

Updated Category News Views 71

Financial Institutions, Inc. Declares Increased Dividend for Shareholders Financial Institutions, Inc. (NASDAQ: FISI), the parent company of Five Star Bank and Courier Capital, has announced an increase in its quarterly cash dividend. This decision reflects the company's sustained commitment to generating long-term value for its shareholders. Details of the Dividend...

Continue Reading
Pea Protein Market Poised for Rapid Growth: Key Drivers Ahead

Updated Category News Views 131

Exploring the Future of the Pea Protein Market The global pea protein market is on the brink of remarkable expansion, set to grow from USD 2.1 billion in 2024 to an impressive USD 3.7 billion by 2029. With a compound annual growth rate (CAGR) of 12.0%, this growth signals a significant shift in consumer preferences aligning towards health, wellness, and sustainability....

Continue Reading
The Unstoppable Rise of Netflix: A Stock to Watch

Updated Category News Views 166

Netflix's Remarkable Stock Journey It may sound surprising that a stock can still be considered irresistible after a staggering 350% increase, especially when it recently reached a new high. However, it’s hard not to feel optimistic about Netflix, Inc (NASDAQ: NFLX). This company, which once experienced a dramatic drop of 80% in its stock value just two years ago, has...

Continue Reading